Tag Archives: Zelboraf

Zelboraf, Cotellic, Similar Melanoma Drugs May Cause Heart Problems: Study

August 14, 2019 By: Irvin Jackson

A new study warns that some melanoma drugs used in combination may increase the risk of serious heart problems.
Melanoma Drug Zelboraf Linked to Pancreatitis Risk, Canadian Officials Warn

February 17, 2015 By: Irvin Jackson

Health Canada has added a pancreatitis warning to the melanoma drug Zelboraf following a safety review.
Zelboraf Side Effects Linked to Risk of Squamous Cell Carcinomas

January 20, 2012 By: Staff Writers

Roche’s melanoma skin cancer pill Zelboraf, actually appears to cause other, less deadly, forms of skin cancer to grow, some researchers report.

Tepezza Hearing Complaints Known By Drug Maker For Years Before Warnings Provided, According to Lawsuits (Posted 3 days ago)

Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.

Dept. of Justice Outlines Option to Settle Camp Lejeune Lawsuits More Quickly (Posted 9 days ago)

The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.

Philips CPAP Class Action Settlement Results in Agreement To Pay $479M To Owners of Recalled Machines (Posted 13 days ago)

A $479 million Philips CPAP class action settlement agreement will resolve claims of economic loss filed by users of the recalled devices.

Tag Archives: Zelboraf

Zelboraf, Cotellic, Similar Melanoma Drugs May Cause Heart Problems: Study

Melanoma Drug Zelboraf Linked to Pancreatitis Risk, Canadian Officials Warn

Zelboraf Side Effects Linked to Risk of Squamous Cell Carcinomas

More Top Stories

Review A Case